<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab12">
 <label>Table 26.12</label>
 <caption>
  <p>Review of 1597 consecutive autopsies of HIV-1-positive patients performed between 1984 and 2000, and division into four time periods on the basis of the therapeutic regimens available (Vago et al. (
   <xref ref-type="bibr" rid="CR138">2002</xref>) reproduced with kind permission by Wolters Kluver Health)
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Year</th>
    <th>Therapy</th>
    <th>
     <italic>n</italic>
    </th>
    <th>HIV-E/L</th>
    <th>Opportunistic infections</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td>1984–1987</td>
    <td>No therapy</td>
    <td>119</td>
    <td>53.8</td>
    <td>40.3</td>
   </tr>
   <tr>
    <td>1988–1994</td>
    <td>Monotherapy (zidovudine)</td>
    <td>1116</td>
    <td>32.2</td>
    <td>46.8</td>
   </tr>
   <tr>
    <td>1995–1996</td>
    <td>Dual combination therapy with nucleoside reverse transcriptase inhibitors</td>
    <td>256</td>
    <td>17.9</td>
    <td>42.6</td>
   </tr>
   <tr>
    <td>1997–2000</td>
    <td>Triple combination therapy including two NRTIs and at least one protease inhibitor or non-NRTI</td>
    <td>106</td>
    <td>15.1</td>
    <td>42.5</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
